Medical News

---

• Asthma associated with flagellated protozoa in sputum
• Premenstrual dysphoric disorder common in bipolar women
• Schizophrenia patients show disrupted axonal fiber connectivity
• PSA doubling time confirmed as predictor of mortality after prostatectomy
• Cancer-inhibiting qualities of pomegranate revealed
• TNXL2 key regulator of breast cancer cell growth
• MI risk increased by triglyceride-associated SNP
• Intensive lipid-lowering therapy uncommon in ACS patients
• High osteoprotegerin predicts all-cause mortality in Type 2 diabetics
• Outreach screening for diabetic retinopathy holds potential
• AF rates after heart surgery similar with metoprolol, amiodarone prophylaxis
• ICDs may raise post-MI death risk

Asthma associated with flagellated protozoa in sputum Posted: 15 Dec 2010 04:00 PM PST Asthma patients are more likely to test positive for flagellated protozoa in their sputum than individuals without the condition, results from an initial study suggest

Premenstrual dysphoric disorder common in bipolar women Posted: 15 Dec 2010 04:00 PM PST More than a quarter of women with bipolar disorder report premenstrual dysphoric disorder and those who do tend to experience multiple other comorbidities, study results show.

Schizophrenia patients show disrupted axonal fiber connectivity Posted: 15 Dec 2010 04:00 PM PST Patients with schizophrenia show widespread disruptions in white-matter connectivity at the macroscale, a finding which is directly related to impaired intellectual performance, the results of a network brain mapping study show.

PSA doubling time confirmed as predictor of mortality after prostatectomy Posted: 14 Dec 2010 04:00 PM PST The time it takes for a man's prostate-specific antigen level to double after radical prostatectomy can be an early indication of whether he is at increased risk for overall or prostate cancer-specific mortality, say researchers.

Cancer-inhibiting qualities of pomegranate revealed Posted: 14 Dec 2010 04:00 PM PST US researchers have identified which elements of pomegranate juice inhibit prostate cancer cell migration, and could therefore offer potential in developing new treatments for the disease.

TNXL2 key regulator of breast cancer cell growth Posted: 14 Dec 2010 04:00 PM PST The redox protein thioredoxin-like 2 controls the growth and metastasis of human breast cancer cells by regulating levels of reactive oxygen species and nuclear factor kappa B activity, study findings indicate.

MI risk increased by triglyceride-associated SNP Posted: 14 Dec 2010 04:00 PM PST A single nucleotide polymorphism in a gene associated with higher fasting triglyceride levels increases the risk for early-onset myocardial infarction, independently of triglyceride levels, Italian scientists have discovered.

Intensive lipid-lowering therapy uncommon in ACS patients Posted: 14 Dec 2010 04:00 PM PST The majority of patients admitted to hospital with acute coronary syndrome do not receive intensive lipid-lowering therapy, say US researchers who call for better implementation of guideline recommendations.

High osteoprotegerin predicts all-cause mortality in Type 2 diabetics Posted: 14 Dec 2010 04:00 PM PST Results show that high levels of osteoprotegerin, which forms part of the tumor necrosis factor receptor superfamily, are associated with increased all-cause mortality in patients with Type 2 diabetes.

Outreach screening for diabetic retinopathy holds potential Posted: 14 Dec 2010 04:00 PM PST Outreach screening for diabetic retinopathy may be an effective alternative to on-site specialist examination, especially in remote and resource poor areas, show results from a meta-analysis of relevant studies.

AF rates after heart surgery similar with metoprolol, amiodarone prophylaxis Posted: 14 Dec 2010 04:00 PM PST Intravenous metoprolol produces similar rates of atrial fibrillation after cardiac surgery as amiodarone, Finnish researchers suggest.

ICDs may raise post-MI death risk Posted: 14 Dec 2010 04:00 PM PST In patients at high risk for sudden death after myocardial infarction, an implantable cardioverter-defibrillator does not reduce overall cardiac-related death risk in the subsequent year, study findings suggest.

You are subscribed to email updates from MedWire Medical News Combined Feed To stop receiving these emails, you may unsubscribe now.	Email delivery powered by Google
Google Inc., 20 West Kinzie, Chicago IL USA 60610